<DOC>
	<DOCNO>NCT02586818</DOCNO>
	<brief_summary>This study design evaluate verify clinical accuracy InRhythm PT/INR system ; point-of-care , whole blood PT/INR measurement reference plasma base PT/INR use laboratory reference instrument reagent ( Sysmex/Innovin ) calibrate WHO rTF09 reference standard .</brief_summary>
	<brief_title>Clinical Performance InRhythm PT/INR System Professional Use Setting</brief_title>
	<detailed_description>The study perform minimum three ( 3 ) different clinical site patient ' VKA therapy manage routine PT/INR monitoring perform .</detailed_description>
	<mesh_term>Hematologic Diseases</mesh_term>
	<criteria>The subject must &gt; 18 year age . The subject must willing competent sign inform consent . The subject must able attend clinic one visit donate one FS blood sample one venous blood draw approximately 10 cc . Additional Inclusion Criteria Therapeutic Group The subject must require oral VKA anticoagulant therapy . The patient must anticoagulated least three month prior enrollment . The subject unable donate fingerstick venous blood sample . The subject history clinically significant bleeding associate incising finger and/or venipuncture . The subject enrol study involve investigational drug and/or device . Additional Exclusion Criteria Normal Group Subjects receive form anticoagulation drug Aspirin Clopidogrel .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>